As Of | Filing | | Doc. | | Page | | Title | Docs. |
---|
| | | |
1/11/24 | | DEFM14A | | | | 1 | | A-1 | 1 |
| | | | | | 1 | | A-16 | 1 |
| | | | | | 1 | | A-19 | 1 |
| | | | | | 1 | | A-20 | 1 |
| | | | | | 1 | | A-21 | 1 |
| | | | | | 1 | | A-22 | 1 |
| | | | | | 1 | | A-23 | 1 |
| | | | | | 1 | | A-26 | 1 |
| | | | | | 1 | | A-27 | 1 |
| | | | | | 1 | | A-28 | 1 |
| | | | | | 1 | | A-29 | 1 |
| | | | | | 1 | | A-31 | 1 |
| | | | | | 1 | | A-32 | 1 |
| | | | | | 1 | | A-34 | 1 |
| | | | | | 1 | | A-37 | 1 |
| | | | | | 1 | | A-39 | 1 |
| | | | | | 1 | | A-41 | 1 |
| | | | | | 1 | | A-42 | 1 |
| | | | | | 1 | | A-43 | 1 |
| | | | | | 1 | | A-44 | 1 |
| | | | | | 1 | | A-45 | 1 |
| | | | | | 1 | | A-46 | 1 |
| | | | | | 1 | | A-47 | 1 |
| | | | | | 1 | | A-48 | 1 |
| | | | | | 1 | | A-49 | 1 |
| | | | | | 1 | | A-51 | 1 |
| | | | | | 1 | | A-53 | 1 |
| | | | | | 1 | | A-54 | 1 |
| | | | | | 1 | | A-59 | 1 |
| | | | | | 1 | | A-61 | 1 |
| | | | | | 1 | | A-63 | 1 |
| | | | | | 1 | | A-65 | 1 |
| | | | | | 1 | | A-68 | 1 |
| | | | | | 1 | | A-7 | 1 |
| | | | | | 1 | | A-70 | 1 |
| | | | | | 1 | | A-71 | 1 |
| | | | | | 1 | | A-73 | 1 |
| | | | | | 1 | | A-74 | 1 |
| | | | | | 1 | | A-75 | 1 |
| | | | | | 1 | | A-76 | 1 |
| | | | | | 1 | | A-77 | 1 |
| | | | | | 1 | | A-79 | 1 |
| | | | | | 1 | | A-80 | 1 |
| | | | | | 1 | | A-81 | 1 |
| | | | | | 1 | | A-82 | 1 |
| | | | | | 1 | | A-83 | 1 |
| | | | | | 1 | | A-84 | 1 |
| | | | | | 1 | | A-86 | 1 |
| | | | | | 1 | | A-87 | 1 |
| | | | | | 1 | | A-88 | 1 |
| | | | | | 1 | | A-89 | 1 |
| | | | | | 1 | | A-90 | 1 |
| | | | | | 1 | | A-91 | 1 |
8/9/23 | | 424B5 | | | | 1 | | About the Registrants | 1 |
| | | | | | 1 | | About This Prospectus | 1 |
| | | | | | 1 | | About This Prospectus Supplement | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Absence of Certain Changes | 1 |
| | | | | | 1 | | Access to Information; Confidentiality | 1 |
| | | | | | 1 | | Accrued Dividends | 1 |
| | | | | | 1 | | Acquisition Proposals; Changes in Recommendation | 1 |
| | | | | | 1 | | Activities of Alpine Sub and Alpine OP Sub | 1 |
| | | | | | 1 | | Additional Agreements | 1 |
| | | | | | 1 | | Adjustments to Prevent Dilution | 1 |
| | | | | | 1 | | Agreement and Plan of Merger | 1 |
| | | | | | 1 | | Amendment | 1 |
| | | | | | 1 | | Amendment and Termination of Company Equity Incentive Plan and Certain Company Employee Programs | 1 |
2/22/24 | | 10-K | | | | 1 | | And 202 | 1 |
8/4/23 | | 10-Q | | | | 1 | | And Six | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Annex A -- Agreement and Plan of Merger | 1 |
| | | | | | 1 | | Annex B -- Opinion of Barclays Capital Inc | 1 |
| | | | | | 1 | | Annex C -- Opinion of Bofa Securities, Inc | 1 |
| | | | | | 1 | | Annex D -- Form of Articles of Amendment to the Healthpeak Charter | 1 |
| | | | | | 1 | | Annex E -- Form of Amendment to the Healthpeak Bylaws | 1 |
| | | | | | 1 | | Article I Definitions | 1 |
| | | | | | 1 | | Article Ii the Mergers | 1 |
| | | | | | 1 | | Article Iii Effects of the Mergers | 1 |
| | | | | | 1 | | Article Iv Representations and Warranties of the Company | 1 |
| | | | | | 1 | | Article Ix Termination | 1 |
| | | | | | 1 | | Article V Representations and Warranties of the Parent | 1 |
| | | | | | 1 | | Article Vi Conduct of Business Pending the Mergers | 1 |
| | | | | | 1 | | Article Vii Covenants | 1 |
| | | | | | 1 | | Article Viii Conditions to the Mergers | 1 |
| | | | | | 1 | | Article X General Provisions | 1 |
| | | | | | 1 | | Assignment; Third-Party Beneficiaries | 1 |
| | | | | | 1 | | Authority | 1 |
| | | | | | 1 | | Authorship | 1 |
| | | | | | 1 | | B-1 | 1 |
2/22/24 | | 10-K | | | | 1 | | Business | 1 |
1/11/24 | | DEFM14A | | | | 1 | | C-1 | 1 |
| | | | | | 1 | | Capitalization | 1 |
| | | | | | 1 | | Cautionary Statement Regarding Forward-Looking Statements | 2 |
| | | | | | 1 | | Certain Definitions | 1 |
8/9/23 | | 424B5 | | | | 1 | | Certain Provisions of Maryland Law and of Our | 1 |
| | | | | | 1 | | Certain Provisions of Maryland Law and of Our Declaration of Trust and Bylaws | 1 |
2/22/24 | | 10-K | | | | 1 | | Certain Relationships and Related Transactions, and Director Independence | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Certain Tax Matters | 1 |
2/22/24 | | 10-K | | | | 1 | | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Choice of Law/Consent to Jurisdiction | 1 |
| | | | | | 1 | | Closing | 1 |
| | | | | | 1 | | Company Credit Facility | 1 |
| | | | | | 1 | | Company Material Contracts | 1 |
| | | | | | 1 | | Comparative Stock Prices and Dividends | 1 |
| | | | | | 1 | | Comparison of Rights of Healthpeak Stockholders and Physicians Realty Trust Shareholders | 1 |
| | | | | | 1 | | Compliance with Applicable Laws | 1 |
| | | | | | 1 | | Conditions to Obligations of the Company Parties | 1 |
| | | | | | 1 | | Conditions to Obligations of the Parent Parties | 1 |
| | | | | | 1 | | Conditions to the Obligations of Each Party to Effect the Mergers | 1 |
| | | | | | 1 | | Conduct of Business by Parent | 1 |
| | | | | | 1 | | Conduct of Business by the Company | 1 |
| | | | | | 1 | | Consents and Approvals; No Violations | 1 |
8/4/23 | | 10-Q | | | | 1 | | Consolidated Balance Sheets as of | 1 |
5/4/23 | | 10-Q | | | | 1 | | Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 | 1 |
10/30/23 | | 10-Q | | | | 1 | | Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 | 1 |
2/22/24 | | 10-K | | | | 1 | | Consolidated Balance Sheets at December 31, 202 | 1 |
8/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Cash Flows for the | 1 |
10/30/23 | | 10-Q | | | | 1 | | Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 | 1 |
5/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022 | 1 |
2/22/24 | | 10-K | | | | 1 | | Consolidated Statements of Cash Flows for the Years Ended December 31, 202 | 1 |
8/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Comprehensive Income for the Three | 1 |
10/30/23 | | 10-Q | | | | 1 | | Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2023 and 2022 | 1 |
5/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2023 and 2022 | 1 |
2/22/24 | | 10-K | | | | 1 | | Consolidated Statements of Comprehensive Income for the Years Ended December 31, 202 | 1 |
8/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Equity for the Three | 1 |
10/30/23 | | 10-Q | | | | 1 | | Consolidated Statements of Equity for the Three and Nine Months Ended September 30, 2023 and 2022 | 1 |
5/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Equity for the Three Months Ended March 31, 2023 and 2022 | 1 |
2/22/24 | | 10-K | | | | 1 | | Consolidated Statements of Equity for the Years Ended December 31, 202 | 1 |
8/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Income for the Three | 1 |
10/30/23 | | 10-Q | | | | 1 | | Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2023 and 2022 | 1 |
5/4/23 | | 10-Q | | | | 1 | | Consolidated Statements of Income for the Three Months Ended March 31, 2023 and 2022 | 1 |
2/22/24 | | 10-K | | | | 1 | | Consolidated Statements of Income for the Years Ended December 31, 202 | 1 |
| | | | | | 1 | | Controls and Procedures | 4 |
1/11/24 | | DEFM14A | | | | 1 | | Counterparts | 1 |
2/22/24 | | 10-K | | | | 1 | | Cybersecurity | 1 |
1/11/24 | | DEFM14A | | | | 1 | | D-1 | 1 |
8/9/23 | | 424B5 | | | | 1 | | Declaration of Trust and Bylaws | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Description of Capital Stock | 1 |
8/9/23 | | 424B5 | | | | 1 | | Description of Debt Securities and Guarantees | 1 |
| | | | | | 1 | | Description of Physicians Realty Trust Depositary Shares | 1 |
| | | | | | 1 | | Description of Physicians Realty Trust Shares of Beneficial Interest | 1 |
| | | | | | 1 | | Description of Physicians Realty Trust Units | 1 |
| | | | | | 1 | | Description of Physicians Realty Trust Warrants | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Directors' and Officers' Indemnification | 1 |
2/22/24 | | 10-K | | | | 1 | | Directors, Executive Officers and Corporate Governance | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Directors, Trustees and Officers | 1 |
2/22/24 | | 10-K | | | | 1 | | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Dividends and Distributions | 1 |
| | | | | | 1 | | E-1 | 1 |
| | | | | | 1 | | Effect of Termination | 1 |
| | | | | | 1 | | Effect on Company Equity Awards; Company ESPP | 1 |
| | | | | | 1 | | Effect on Equity Interests | 1 |
| | | | | | 1 | | Employee Benefit Plans | 1 |
| | | | | | 1 | | Employment Matters | 1 |
| | | | | | 1 | | Entire Agreement | 1 |
| | | | | | 1 | | Environmental Matters | 1 |
| | | | | | 1 | | Equivalent and Comparative Per Share Information | 1 |
| | | | | | 1 | | Exchange of Certificates | 1 |
2/22/24 | | 10-K | | | | 1 | | Executive Compensation | 1 |
10/30/23 | | 10-Q | | | | 1 | | Exhibits | 3 |
2/22/24 | | 10-K | | | | 1 | | Exhibits, Financial Statement Schedules | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Existence; Good Standing; Compliance with Law | 1 |
| | | | | | 1 | | Experts | 2 |
| | | | | | 1 | | Extension; Waiver | 1 |
10/30/23 | | 10-Q | | | | 1 | | Financial Information | 3 |
| | | | | | 1 | | Financial Statements (Unaudited) | 3 |
2/22/24 | | 10-K | | | | 1 | | Financial Statements and Supplementary Data | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Financing Cooperation | 1 |
2/22/24 | | 10-K | | | | 1 | | Form 10-K Summary | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Form of Amendment to the Healthpeak Bylaws | 1 |
| | | | | | 1 | | Form of Articles of Amendment to the Healthpeak Charter | 1 |
| | | | | | 1 | | Future Stockholder and Shareholder Proposals | 1 |
| | | | | | 1 | | Healthpeak Proposals | 1 |
| | | | | | 1 | | Healthpeak Special Meeting, The | 1 |
8/9/23 | | 424B5 | | | | 1 | | Incorporation by Reference | 1 |
| | | | | | 1 | | Incorporation of Certain Documents by Reference | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Information About the Companies | 1 |
| | | | | | 1 | | Information Supplied | 1 |
| | | | | | 1 | | Insurance | 1 |
| | | | | | 1 | | Intellectual Property | 1 |
| | | | | | 1 | | Interpretation | 1 |
| | | | | | 1 | | Investment Company Act | 1 |
10/30/23 | | 10-Q | | | | 1 | | Item 1 | 3 |
| | | | | | 1 | | Item 1A | 3 |
| | | | | | 1 | | Item 2 | 3 |
| | | | | | 1 | | Item 3 | 3 |
| | | | | | 1 | | Item 4 | 3 |
| | | | | | 1 | | Item 5 | 2 |
| | | | | | 1 | | Item 6 | 3 |
8/4/23 | | 10-Q | | | | 1 | | June | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Labor and Employment Matters | 1 |
| | | | | | 1 | | Legal Matters | 2 |
2/22/24 | | 10-K | | | | 1 | | Legal Proceedings | 4 |
1/11/24 | | DEFM14A | | | | 1 | | Litigation | 1 |
| | | | | | 1 | | Lost Certificates | 1 |
2/22/24 | | 10-K | | | | 1 | | Management's Discussion and Analysis of Financial Condition and Results of Operations | 4 |
| | | | | | 1 | | Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Material U.S. Federal Income Tax Consequences | 1 |
8/9/23 | | 424B5 | | | | 1 | | Material U.S. Federal Income Tax Considerations | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Merger Agreement, The | 1 |
| | | | | | 1 | | Mergers, The | 1 |
2/22/24 | | 10-K | | | | 1 | | Mine Safety Disclosures | 1 |
8/4/23 | | 10-Q | | | | 1 | | Months Ended | 1 |
2/22/24 | | 10-K | | | | 1 | | Mortgage Loans on Real Estate | 1 |
1/11/24 | | DEFM14A | | | | 1 | | No Brokers | 1 |
| | | | | | 1 | | No Control of Other Party's Business | 1 |
| | | | | | 1 | | No Dissenters' Rights | 1 |
| | | | | | 1 | | No Fractional Shares | 1 |
| | | | | | 1 | | No Other Representations or Warranties | 1 |
| | | | | | 1 | | Non-Survival of Representations and Warranties | 1 |
2/22/24 | | 10-K | | | | 1 | | Notes to Consolidated Financial Statements | 4 |
1/11/24 | | DEFM14A | | | | 1 | | Notices | 1 |
| | | | | | 1 | | Notification of Certain Matters; Transaction Litigation | 1 |
8/9/23 | | 424B5 | | | | 1 | | Offering, The | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Opinion of Barclays Capital Inc | 1 |
| | | | | | 1 | | Opinion of Bofa Securities, Inc | 1 |
| | | | | | 1 | | Opinion of Financial Advisor | 1 |
| | | | | | 1 | | Organizational Documents | 1 |
| | | | | | 1 | | Other Filings | 1 |
2/22/24 | | 10-K | | | | 1 | | Other Information | 4 |
1/11/24 | | DEFM14A | | | | 1 | | Other Interests | 1 |
| | | | | | 1 | | Other Matters | 1 |
| | | | | | 1 | | Parent Board; Trading Symbol | 1 |
2/22/24 | | 10-K | | | | 1 | | Part I | 4 |
| | | | | | 1 | | Part Ii | 4 |
| | | | | | 1 | | Part Iii | 1 |
| | | | | | 1 | | Part Iv | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Payment of Expense Amount or Termination Fee | 1 |
| | | | | | 1 | | Physicians Realty Trust Proposals | 1 |
| | | | | | 1 | | Physicians Realty Trust Special Meeting, The | 1 |
8/9/23 | | 424B5 | | | | 1 | | Plan of Distribution | 1 |
| | | | | | 1 | | Plan of Distribution (Conflicts of Interest) | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Potential Property Management Agreements | 1 |
2/22/24 | | 10-K | | | | 1 | | Power of Attorney (included on signature pages) | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Preparation of the Form S-4 and the Proxy Statement/Prospectus; Company Shareholder Meeting; Parent Stockholder Meeting; Listing Application | 1 |
2/22/24 | | 10-K | | | | 1 | | Principal Accountant Fees and Services | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Privacy and Data Security | 1 |
2/22/24 | | 10-K | | | | 1 | | Properties | 2 |
8/9/23 | | 424B5 | | | | 1 | | Prospectus Supplement Summary | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Public Announcements | 1 |
2/22/24 | | 10-K | | | | 1 | | Quantitative and Qualitative Disclosures About Market Risk | 4 |
1/11/24 | | DEFM14A | | | | 1 | | Questions and Answers | 1 |
2/22/24 | | 10-K | | | | 1 | | Real Estate and Accumulated Depreciation | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Registration Rights Agreements | 1 |
| | | | | | 1 | | Related Party Transactions | 1 |
| | | | | | 1 | | Remedies | 1 |
2/22/24 | | 10-K | | | | 1 | | Report of Independent Registered Public Accounting Firm | 1 |
| | | | | | 1 | | Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting | 1 |
| | | | | | 1 | | Reserved | 1 |
| | | | | | 1 | | Risk Factors | 6 |
| | | | | | 1 | | Schedule III -- Real Estate and Accumulated Depreciation | 1 |
| | | | | | 1 | | Schedule IV -- Mortgage Loans on Real Estate | 1 |
1/11/24 | | DEFM14A | | | | 1 | | SEC Reports, Financial Statements and Internal Controls | 1 |
| | | | | | 1 | | Section 1.1 | 1 |
| | | | | | 1 | | Section 1.2 | 1 |
| | | | | | 1 | | Section 10.1 | 1 |
| | | | | | 1 | | Section 10.10 | 1 |
| | | | | | 1 | | Section 10.11 | 1 |
| | | | | | 1 | | Section 10.12 | 1 |
| | | | | | 1 | | Section 10.13 | 1 |
| | | | | | 1 | | Section 10.2 | 1 |
| | | | | | 1 | | Section 10.3 | 1 |
| | | | | | 1 | | Section 10.4 | 1 |
| | | | | | 1 | | Section 10.5 | 1 |
| | | | | | 1 | | Section 10.6 | 1 |
| | | | | | 1 | | Section 10.7 | 1 |
| | | | | | 1 | | Section 10.8 | 1 |
| | | | | | 1 | | Section 10.9 | 1 |
| | | | | | 1 | | Section 16 Matters | 1 |
| | | | | | 1 | | Section 2.1 | 1 |
| | | | | | 1 | | Section 2.2 | 1 |
| | | | | | 1 | | Section 2.3 | 1 |
| | | | | | 1 | | Section 2.4 | 1 |
| | | | | | 1 | | Section 2.5 | 1 |
| | | | | | 1 | | Section 3.1 | 1 |
| | | | | | 1 | | Section 3.2 | 1 |
| | | | | | 1 | | Section 3.3 | 1 |
| | | | | | 1 | | Section 3.4 | 1 |
| | | | | | 1 | | Section 3.5 | 1 |
| | | | | | 1 | | Section 3.6 | 1 |
| | | | | | 1 | | Section 3.7 | 1 |
| | | | | | 1 | | Section 3.8 | 1 |
| | | | | | 1 | | Section 4.1 | 1 |
| | | | | | 1 | | Section 4.10 | 1 |
| | | | | | 1 | | Section 4.11 | 1 |
| | | | | | 1 | | Section 4.12 | 1 |
| | | | | | 1 | | Section 4.13 | 1 |
| | | | | | 1 | | Section 4.14 | 1 |
| | | | | | 1 | | Section 4.15 | 1 |
| | | | | | 1 | | Section 4.16 | 1 |
| | | | | | 1 | | Section 4.17 | 1 |
| | | | | | 1 | | Section 4.18 | 1 |
| | | | | | 1 | | Section 4.19 | 1 |
| | | | | | 1 | | Section 4.2 | 1 |
| | | | | | 1 | | Section 4.20 | 1 |
| | | | | | 1 | | Section 4.21 | 1 |
| | | | | | 1 | | Section 4.22 | 1 |
| | | | | | 1 | | Section 4.23 | 1 |
| | | | | | 1 | | Section 4.24 | 1 |
| | | | | | 1 | | Section 4.25 | 1 |
| | | | | | 1 | | Section 4.26 | 1 |
| | | | | | 1 | | Section 4.27 | 1 |
| | | | | | 1 | | Section 4.3 | 1 |
| | | | | | 1 | | Section 4.4 | 1 |
| | | | | | 1 | | Section 4.5 | 1 |
| | | | | | 1 | | Section 4.6 | 1 |
| | | | | | 1 | | Section 4.7 | 1 |
| | | | | | 1 | | Section 4.8 | 1 |
| | | | | | 1 | | Section 4.9 | 1 |
| | | | | | 1 | | Section 5.1 | 1 |
| | | | | | 1 | | Section 5.10 | 1 |
| | | | | | 1 | | Section 5.11 | 1 |
| | | | | | 1 | | Section 5.12 | 1 |
| | | | | | 1 | | Section 5.13 | 1 |
| | | | | | 1 | | Section 5.14 | 1 |
| | | | | | 1 | | Section 5.15 | 1 |
| | | | | | 1 | | Section 5.16 | 1 |
| | | | | | 1 | | Section 5.17 | 1 |
| | | | | | 1 | | Section 5.18 | 1 |
| | | | | | 1 | | Section 5.19 | 1 |
| | | | | | 1 | | Section 5.2 | 1 |
| | | | | | 1 | | Section 5.3 | 1 |
| | | | | | 1 | | Section 5.4 | 1 |
| | | | | | 1 | | Section 5.5 | 1 |
| | | | | | 1 | | Section 5.6 | 1 |
| | | | | | 1 | | Section 5.7 | 1 |
| | | | | | 1 | | Section 5.8 | 1 |
| | | | | | 1 | | Section 5.9 | 1 |
| | | | | | 1 | | Section 6.1 | 1 |
| | | | | | 1 | | Section 6.2 | 1 |
| | | | | | 1 | | Section 6.3 | 1 |
| | | | | | 1 | | Section 7.1 | 1 |
| | | | | | 1 | | Section 7.10 | 1 |
| | | | | | 1 | | Section 7.11 | 1 |
| | | | | | 1 | | Section 7.12 | 1 |
| | | | | | 1 | | Section 7.13 | 1 |
| | | | | | 1 | | Section 7.14 | 1 |
| | | | | | 1 | | Section 7.15 | 1 |
| | | | | | 1 | | Section 7.16 | 1 |
| | | | | | 1 | | Section 7.17 | 1 |
| | | | | | 1 | | Section 7.18 | 1 |
| | | | | | 1 | | Section 7.19 | 1 |
| | | | | | 1 | | Section 7.2 | 1 |
| | | | | | 1 | | Section 7.20 | 1 |
| | | | | | 1 | | Section 7.21 | 1 |
| | | | | | 1 | | Section 7.22 | 1 |
| | | | | | 1 | | Section 7.3 | 1 |
| | | | | | 1 | | Section 7.4 | 1 |
| | | | | | 1 | | Section 7.5 | 1 |
| | | | | | 1 | | Section 7.6 | 1 |
| | | | | | 1 | | Section 7.7 | 1 |
| | | | | | 1 | | Section 7.8 | 1 |
| | | | | | 1 | | Section 7.9 | 1 |
| | | | | | 1 | | Section 8.1 | 1 |
| | | | | | 1 | | Section 8.2 | 1 |
| | | | | | 1 | | Section 8.3 | 1 |
| | | | | | 1 | | Section 9.1 | 1 |
| | | | | | 1 | | Section 9.2 | 1 |
| | | | | | 1 | | Section 9.3 | 1 |
| | | | | | 1 | | Section 9.4 | 1 |
8/9/23 | | 424B5 | | | | 1 | | Securities That May Be Offered | 1 |
2/22/24 | | 10-K | | | | 1 | | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Security Ownership of Certain Beneficial Owners of Healthpeak Common Stock | 1 |
| | | | | | 1 | | Security Ownership of Certain Beneficial Owners of Physicians Realty Trust Common Shares | 1 |
8/9/23 | | 424B5 | | | | 1 | | Selling Securityholders | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Severability | 1 |
10/30/23 | | 10-Q | | | | 1 | | Signatures | 3 |
8/4/23 | | 10-Q | | | | 1 | | Six | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Subsidiary Interests | 1 |
| | | | | | 1 | | Summary | 1 |
| | | | | | 1 | | Table of Contents | 4 |
| | | | | | 1 | | Takeover Statute | 1 |
| | | | | | 1 | | Takeover Statutes | 1 |
| | | | | | 1 | | Tax Representation Letters | 1 |
| | | | | | 1 | | Taxes | 1 |
| | | | | | 1 | | Termination | 1 |
| | | | | | 1 | | Termination Fees and Expense Amount | 1 |
| | | | | | 1 | | Terms Defined Elsewhere | 1 |
| | | | | | 1 | | The Healthpeak Special Meeting | 1 |
| | | | | | 1 | | The Merger Agreement | 1 |
| | | | | | 1 | | The Mergers | 1 |
8/9/23 | | 424B5 | | | | 1 | | The Offering | 1 |
1/11/24 | | DEFM14A | | | | 1 | | The Physicians Realty Trust Special Meeting | 1 |
| | | | | | 1 | | Transaction Structure | 1 |
| | | | | | 1 | | Unaudited Pro Forma Condensed Combined Financial Statements | 1 |
8/4/23 | | 10-Q | | | | 1 | | Unregistered Sales of Equity Securities and Use of Proceeds | 2 |
10/30/23 | | 10-Q | | | | 1 | | Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities | 1 |
2/22/24 | | 10-K | | | | 1 | | Unresolved Staff Comments | 1 |
8/9/23 | | 424B5 | | | | 1 | | Use of Proceeds | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Vote Required | 1 |
| | | | | | 1 | | Voting of Company Common Shares and Parent Common Stock | 1 |
| | | | | | 1 | | Waiver of Jury Trial | 1 |
8/9/23 | | 424B5 | | | | 1 | | Where You Can Find Additional Information | 1 |
1/11/24 | | DEFM14A | | | | 1 | | Where You Can Find More Information | 2 |
| | | | | | 1 | | Withholding Rights | 1 |
2/22/24 | | 10-K | | | | 1 | | 101 | 1 |
| | | | | | 1 | | 108 | 1 |
| | | | | | 1 | | 109 | 1 |
| | | | | | 1 | | 110 | 1 |
| | | | | | 1 | | 111 | 1 |
1/11/24 | | DEFM14A | | | | 1 | | 121 | 1 |
2/22/24 | | 10-K | | | | 1 | | 127 | 1 |
1/11/24 | | DEFM14A | | | | 1 | | 147 | 1 |
| | | | | | 1 | | 150 | 1 |
2/22/24 | | 10-K | | | | 1 | | 151 | 1 |
| | | | | | 1 | | 153 | 2 |
| | | | | | 1 | | 154 | 1 |
| | | | | | 1 | | 156 | 1 |
| | | | | | 1 | | 157 | 2 |
1/11/24 | | DEFM14A | | | | 1 | | 160 | 1 |
| | | | | | 1 | | 162 | 1 |
| | | | | | 1 | | 185 | 1 |
| | | | | | 1 | | 195 | 1 |
| | | | | | 1 | | 197 | 1 |
| | | | | | 1 | | 199 | 1 |
2/22/24 | | 10-K | | | | 1 | | 202 | 1 |
8/4/23 | | 10-Q | | | | 1 | | 2023 and 2022 | 1 |
| | | | | | 1 | | 2023 and December 31, 2022 | 1 |
1/11/24 | | DEFM14A | | | | 1 | | 220 | 1 |
| | | | | | 1 | | 221 | 1 |
| | | | | | 1 | | 222 | 1 |
| | | | | | 1 | | 224 | 1 |
| | | | | | 1 | | 225 | 1 |
2/22/24 | | 10-K | | | | 1 | | 24.1 | 1 |